We’re Collecting Information on Ebglyss^® in Pregnancy

MotherToBaby is currently enrolling participants into an observational study examining the use of Ebglyss^® when taken during pregnancy. Our research is by observation only—we will not ask you to take or change any medications. If you join our Ebglyss^® study, our team will simply collect some information about your pregnancy and your baby’s development for a period of time after birth.

This study is by observation only—we will never ask you to start, stop, or change any medication. If you choose to participate in our Ebglyss^® study, our team will simply collect information about your pregnancy and your baby’s growth and development development through the first year of life. 

“Help us improve the ability for pregnant people and their healthcare providers to make more informed treatment decisions by joining our Ebglyss^® & pregnancy study”

— Christina Chambers, PhD, MPH, Lead Investigator, MotherToBaby Pregnancy Studies

Our Ebglyss^® study includes

• 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
• Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.
• An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor.
• A neurodevelopment assessment that can also provide insight into the child’s development at approximately 12 months of age.

If you have eczema (atopic dermatitis) and have taken Ebglyss^® at any point from 123 days before conception through your current pregnancy, you may qualify for this important study.

Will you take the next step and help us learn more about the use of Ebglyss^® during pregnancy?

Help Us Better Understand the Possible Effects of Sotyktu® in Pregnancy

Many people need to take medication during pregnancy to appropriately manage a chronic health condition. In some cases, avoiding or stopping medication use during pregnancy may be more harmful than taking medication. Yet fewer than 10% of medications have enough information to determine their safety for use in pregnancy — this is where you come in!

MotherToBaby is currently enrolling people who are pregnant in a study examining the use of Sotyktu® (deucravacitinib) during pregnancy.

Are you currently pregnant? Did you take Sotyktu® at any point in your current pregnancy? If you answered “yes” to both of these questions, then you have the opportunity to help us learn more about Sotyktu® use in pregnancy.

Will you take the step and become our partner? Make an impact on the health of future families today by joining our Sotyktu® & Pregnancy Study!

Help Us Understand the Effects of Hidradenitis Suppurativa in Pregnancy

Many people need to take medication during pregnancy to appropriately manage their hidradenitis suppurativa (HS). Yet fewer than 10% of medications have enough information to determine their safety for use in pregnancy — this is where we need you as our partner!

Do you have HS? Are you currently pregnant? If you answered “yes” to both of these questions, you may be able to help us advance our knowledge of how HS and its management can affect a pregnancy and a developing baby.

Will you take the step and become our partner? Make an impact on the health of future moms and babies today by joining our Hidradenitis Suppurativa & Pregnancy Study!

Help Us Understand the Effects of nr-axSpA in Pregnancy

Many people need to take medication during pregnancy to appropriately manage their non-radiographic axial spondyloarthritis (nr-axSpA). Yet fewer than 10% of medications have enough information to determine their safety for use in pregnancy — this is where we need you as our partner!

Do you have non-radiographic axial spondyloarthritis? Are you currently pregnant? If you answered “yes” to both of these questions, you may be able to help us advance our knowledge of how non-radiographic axial spondyloarthritis and its management can affect a pregnancy and a developing baby.

Will you take the step and become our partner? Make an impact on the health of future families today by joining our Non-Radiographic Axial Spondyloarthritis & Pregnancy Study!

Help Us Better Understand the Effects of Bimzelx® in Pregnancy

Many people need to take medication during pregnancy to appropriately manage a chronic health condition. In some cases, avoiding or stopping medication use during pregnancy may be more harmful than taking medication. Yet fewer than 10% of medications have enough information to determine their safety for use in pregnancy — this is where you come in!

MotherToBaby is currently enrolling people who are pregnant in a study examining the use of Bimzelx® (bimekizumab-bkzx) to treat psoriasis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and ankylosing spondylitis during pregnancy.

Are you currently pregnant? Did you take Bimzelx® at any point in your current pregnancy? If you answered “yes” to both of these questions, then you have the opportunity to help us learn more about Bimzelx® use in pregnancy.

Will you take the step and become our partner? Make an impact on the health of future families today by joining our Bimzelx® & Pregnancy Study!